SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001554795-14-000264
Filing Date
2014-04-04
Accepted
2014-04-04 16:02:56
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-1 gnbt4114forms1.htm S-1 5738497
2 EXHIBIT 5.1 gnbt4114s1ex5_1.htm EX-5.1 7208
3 EXHIBIT 2.31 gnbt4114s1exh23_1.htm EX-23.1 2398
4 EXHIBIT 23.2 gnbt4114s1exh23_2.htm EX-23.2 2650
11 GRAPHIC header.jpg GRAPHIC 9469
  Complete submission text file 0001554795-14-000264.txt   18714301

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20130731.xml EX-101.INS 2133340
6 XBRL SCHEMA FILE gnbt-20130731.xsd EX-101.SCH 185657
7 XBRL CALCULATION FILE gnbt-20130731_cal.xml EX-101.CAL 91203
8 XBRL DEFINITION FILE gnbt-20130731_def.xml EX-101.DEF 312481
9 XBRL LABEL FILE gnbt-20130731_lab.xml EX-101.LAB 1176712
10 XBRL PRESENTATION FILE gnbt-20130731_pre.xml EX-101.PRE 708726
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0314
Type: S-1 | Act: 33 | File No.: 333-195057 | Film No.: 14745955
SIC: 2834 Pharmaceutical Preparations